Two Sigma Securities, LLC Veru Inc. Transaction History

Two Sigma Securities, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$0.76 - $1.79 $20,380 - $48,000	26,816 New	26,816 $22,000
Q4 2023 Feb 14, 2024	SELL	$0.67 - $1.17 $9,558 - $16,692	-14,267 Reduced 46.43%	16,458 $11,000
Q3 2023 Nov 14, 2023	SELL	$0.72 - $1.33 $22,859 - $42,226	-31,749 Reduced 50.82%	30,725 $22,000
Q2 2023 Aug 14, 2023	BUY	$0.98 - $1.49 $61,224 - $93,086	62,474 New	62,474 $74,000
Q1 2022 May 16, 2022	SELL	$4.55 - $6.41 $53,043 - $74,727	-11,658 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$5.89 - $9.73 $68,665 - $113,432	11,658 New	11,658 $69,000
Q1 2021 May 17, 2021	SELL	$8.05 - $20.78 $222,316 - $573,881	-27,617 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$2.36 - $9.99 $65,176 - $275,893	27,617 New	27,617 $239,000
Q3 2019 Nov 14, 2019	SELL	$1.81 - $2.36 $19,824 - $25,849	-10,953 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$1.26 - $2.14 $13,800 - $23,439	10,953 New	10,953 $23,000

122

56.8M

668K

531K

Ticker VERU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 80,146,704
Market Cap $46.5M
Description
Veru Inc., an oncology biopharmaceutical company, focuses on developing medicines for the management of cancers. Its commercial products comprise FC2 female condom/internal condom for the dual protection against unintended pregnancy and the transmission of sexually transmitted infections for ministries of health, government health agencies, U.N....

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Securities, LLC with notifications on news.